Lyra Therapeutics LYRA
LYRA
$0.15 +0.12 (+400.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lyra Therapeutics (LYRA) Selling, General & Administrative (2019 - 2025)

Updated

Lyra Therapeutics (LYRA) recorded Selling, General & Administrative of $2.54 million in Q4 2025, down 29.7% from $3.61 million a year earlier but up 13.6% from the prior quarter.

Analysis

Lyra Therapeutics (LYRA) Selling, General & Administrative (2019 - 2025) Analysis & Trends

For FY2025, Lyra Therapeutics reported Selling, General & Administrative of $11.54 million, down 37.6% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $18.5 million in FY2024 (-2.9%), $19.06 million in FY2023 (+8.5%), $17.56 million in FY2022 (+23.6%) and $14.21 million in FY2021 (+46.7%).
  • Quarterly Selling, General & Administrative has ranged from $2.24 million in Q3 2025 to $5.82 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative has declined for six consecutive quarters, with an average decline of 20.1% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 138.4% in Q1 2021, against a decline of 43.9% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.24 million (Q3 2025), $3.5 million (Q2 2025) and $3.26 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Lyra Therapeutics 266,232.31 266,232.31 - 2.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.54 Mn
Sep 30, 2025 2.24 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 3.26 Mn
Dec 31, 2024 3.61 Mn
Sep 30, 2024 3.93 Mn
Jun 30, 2024 5.14 Mn
Mar 31, 2024 5.82 Mn
Dec 31, 2023 4.36 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2023 4.57 Mn
Mar 31, 2023 5.13 Mn
Dec 31, 2022 4.40 Mn
Sep 30, 2022 5.14 Mn
Jun 30, 2022 4.13 Mn
Mar 31, 2022 3.89 Mn
Dec 31, 2021 3.57 Mn
Sep 30, 2021 4.02 Mn
Jun 30, 2021 3.56 Mn
Mar 31, 2021 3.06 Mn
API Access

Lyra Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LYRA&period=max&api_key=YOUR_API_KEY